This is a demo store. No orders will be fulfilled.

Bozitinib (PLB-1001) - 10mM in DMSO, high purity , CAS No.1440964-89-5, Inhibitor of MET proto-oncogene; receptor tyrosine kinase

In stock
Item Number
B421621
Grouped product items
SKU Size
Availability
Price Qty
B421621-1ml
1ml
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$241.90

c-Met Inhibitors

Basic Description

Synonyms Bozitinib | Vebreltinib | 1440964-89-5 | PLB-1001 | APL-101 | Bozitinib (PLB-1001) | Vebreltinib [USAN] | CBT-101 | CBI-3103 | 2WZP8A9VFN | 6-(1-cyclopropylpyrazol-4-yl)-3-[difluoro-(6-fluoro-2-methylindazol-5-yl)methyl]-[1,2,4]triazolo[4,3-b]pyridazine | 1,2,4-Triazolo(4,3-b)
Specifications & Purity Moligand™, 10mM in DMSO
Biochemical and Physiological Mechanisms Bozitinib (PLB-1001, CBT-101, APL-101, CBI-3103) is a highly selective ATP-competitive c-Met inhibitor with blood-brain barrier permeability. Bozitinib (PLB-1001) selectively inhibits MET-altered tumor cells in preclinical models.
Storage Temp Store at -80°C
Shipped In
Ice chest + Ice pads
This product requires cold chain shipping. Ground and other economy services are not available.
Grade Moligand™
Action Type INHIBITOR
Mechanism of action Inhibitor of MET proto-oncogene; receptor tyrosine kinase
Product Description

Information

Bozitinib (PLB-1001) Bozitinib (PLB-1001, CBT-101, APL-101, CBI-3103) is a highly selective ATP-competitive c-Met inhibitor with blood-brain barrier permeability. Bozitinib (PLB-1001) selectively inhibits MET-altered tumor cells in preclinical models.

Targets

c-Met

Taxonomic Classification

Taxonomy Tree

Kingdom Organic compounds
Superclass Organoheterocyclic compounds
Class Triazolopyridazines
Subclass Not available
Intermediate Tree Nodes Not available
Direct Parent Triazolopyridazines
Alternative Parents Indazoles  Pyridazines and derivatives  Benzenoids  Aryl fluorides  Triazoles  Pyrazoles  Heteroaromatic compounds  Azacyclic compounds  Organopnictogen compounds  Organonitrogen compounds  Organofluorides  Hydrocarbon derivatives  Alkyl fluorides  
Molecular Framework Aromatic heteropolycyclic compounds
Substituents Triazolopyridazine - Indazole - Benzopyrazole - Benzenoid - Pyridazine - Aryl halide - Aryl fluoride - Heteroaromatic compound - 1,2,4-triazole - Pyrazole - Azole - Azacycle - Organic nitrogen compound - Organopnictogen compound - Hydrocarbon derivative - Organonitrogen compound - Organofluoride - Organohalogen compound - Alkyl halide - Alkyl fluoride - Aromatic heteropolycyclic compound
Description This compound belongs to the class of organic compounds known as triazolopyridazines. These are polycyclic compounds containing a triazole fused to a pyridazine. Triazole is a five-membered ring consisting of two carbon atoms and three nitrogen atoms. Pyridazine is a six-membered aromatic ring with two adjacent nitrogen atoms, and for carbon atoms.
External Descriptors Not available

Product Properties

ALogP 3.548
hba_count 5
Rotatable Bond 4

Associated Targets(Human)

MET Tclin Hepatocyte growth factor receptor (0 Activities)
Activity Type Activity Value -log(M) Mechanism of Action Activity Reference Publications (PubMed IDs)

Names and Identifiers

IUPAC Name 6-(1-cyclopropylpyrazol-4-yl)-3-[difluoro-(6-fluoro-2-methylindazol-5-yl)methyl]-[1,2,4]triazolo[4,3-b]pyridazine
INCHI InChI=1S/C20H15F3N8/c1-29-9-11-6-14(15(21)7-17(11)27-29)20(22,23)19-26-25-18-5-4-16(28-31(18)19)12-8-24-30(10-12)13-2-3-13/h4-10,13H,2-3H2,1H3
InChIKey QHXLXUIZUCJRKV-UHFFFAOYSA-N
Smiles CN1C=C2C=C(C(=CC2=N1)F)C(C3=NN=C4N3N=C(C=C4)C5=CN(N=C5)C6CC6)(F)F
Isomeric SMILES CN1C=C2C=C(C(=CC2=N1)F)C(C3=NN=C4N3N=C(C=C4)C5=CN(N=C5)C6CC6)(F)F
Molecular Weight 424.38
Reaxy-Rn 26647178
Reaxys-RN_link_address https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN=26647178&ln=

Certificates(CoA,COO,BSE/TSE and Analysis Chart)

C of A & Other Certificates(BSE/TSE, COO):
Analytical Chart:

Chemical and Physical Properties

DMSO(mg / mL) Max Solubility 85
DMSO(mM) Max Solubility 200.292190960931
Water(mg / mL) Max Solubility <1
Molecular Weight 424.400 g/mol
XLogP3 2.100
Hydrogen Bond Donor Count 0
Hydrogen Bond Acceptor Count 8
Rotatable Bond Count 4
Exact Mass 424.137 Da
Monoisotopic Mass 424.137 Da
Topological Polar Surface Area 78.700 Ų
Heavy Atom Count 31
Formal Charge 0
Complexity 681.000
Isotope Atom Count 0
Defined Atom Stereocenter Count 0
Undefined Atom Stereocenter Count 0
Defined Bond Stereocenter Count 0
Undefined Bond Stereocenter Count 0
The total count of all stereochemical bonds 0
Covalently-Bonded Unit Count 1

Citations of This Product

1. Bie Songtao, Yuan Hui, Shi Chen, Li Chunshuang, Lu Ming, Yao Ze, Liu Ruobing, Lu Ding, Ma Tenglong, Yu Heshui.  (2025)  Antibiofilm activity of Plumbagin against Staphylococcus aureus.  Scientific Reports,  15  (1): (1-11). 
2. Chenyu Cao, Yifei Li, Fangzhou Shi, Shanshan Jiang, Yutong Li, Leilei Yang, Xinyi Zhou, Yuqiong Gao, Feiyan Tang, Huan Li, Shulan Han, Zhuo Yu, Yifang Zou, Jianfeng Guo.  (2024)  Nano co-delivery of doxorubicin and plumbagin achieves synergistic chemotherapy of hepatocellular carcinoma.  INTERNATIONAL JOURNAL OF PHARMACEUTICS,  661  (124424). 

Solution Calculators

Reviews

Customer Reviews

Shall we send you a message when we have discounts available?

Remind me later

Thank you! Please check your email inbox to confirm.

Oops! Notifications are disabled.